Melatonin increases survival and inhibits oxidative ...

Journal of Neurochemistry, 2003, 86, 1312

CORRECTION

doi:10.1046/j.1471-4159.2003.01997.x

Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease Etsuro Matsubara,* Tara Bryant-Thomas,  Javier Pacheco,  Tracey L. Henry,  Burkhard Poeggeler,  Donald Herbert,  Felix Cruz-Sanchez,à Yau-Jan Chyan,  Mark A. Smith,§ George Perry,§ Daniel G. Chain,–– Eyal Neria,–– Mikio Shoji,* Koji Abe,* Anna Leone,– Inge Grundke-Iqbal,** Glen L. Wilson,  Jorge Ghiso,   Christina Williams,àà Lorenzo M. Refolo,§§ and Miguel A. Pappolla  *Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan  University of South Alabama, Mobile, Alabama, USA àInstitute of Neurological and Gerontological Sciences, International University of Catalonia, Barcelona, Spain §Case Western Reserve University, Cleveland, Ohio –Oxonon, Emeryville, California **New York Institute for Basic Research, New York   New York University, New York ààDuke University, Durham, North Carolina §§Institute for the Study of Aging, New York, USA ––Mindset BioPharmaceuticals, Jerusalem, Israel

The authors wish to make a correction to the above article that was published in J. Neurochem. 85, pp. 1101–1108. Authors Daniel G. Chain and Eyal Neria were omitted and this has been amended above. The authors also wish to

1312

acknowledge that this work has been supported by a NIA grant AG 16783 and by Mindset BioPharmaceuticals (USA) Inc.

Ó 2003 International Society for Neurochemistry, J. Neurochem. (2003) 86, 1312